HHS issued the amendment in order to increase access to childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children return to daycare and school.
Guidance is provided for physicians to optimize telemedicine, which can be challenging for older patients.
A phase 3 trial evaluating LY-CoV555 for the prevention of SARS-CoV-2 infection and COVID-19 in residents and staff of long-term care facilities has been initiated.
Cost-related prescription nonadherence is highest among younger US women compared with individuals living in 10 other high-income countries.
Immunity passport policies for COVID-19 should be communicated as stop-gap measures within wider, multipronged approaches to help society transition out of restrictive measures.
Phase 3 trial initiated evaluating the vaccine candidate mRNA-1273 against COVID-19.
The US Department of Health and Human Services and the Department of Defense have agreed to receive 100 million doses of BNT162, a vaccine for SARS-CoV-2, once the manufacturers obtains approval or emergency use authorization (EUA) from the FDA
A nationwide, coordinated effort is needed to successfully implement widespread wearing of face masks to help slow the spread of COVID-19.
The US government should make immediate preparations for clinical trials in which volunteers are exposed to the new coronavirus to speed development of a vaccine.
Participants demonstrated high levels of neutralizing antibody activity that exceeded those seen in convalescent sera obtained from persons with confirmed COVID-19.